HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes with the Boston Type 1 Keratoprosthesis at Instituto de Microcirugía Ocular IMO.

AbstractPURPOSE:
To report the outcomes on the Boston Type 1 Keratoprosthesis at our institution.
DESIGN:
Retrospective analysis case series.
PARTICIPANTS:
We analyzed 54 eyes of 53 patients who previously underwent Boston Type 1 Keratoprosthesis surgery at our institution from July 2006 to March 2011.
METHODS:
Preoperative and postoperative parameters were collected and analyzed.
MAIN OUTCOME MEASURES:
Visual acuity and keratoprosthesis stability.
RESULTS:
Common preoperative diagnoses were penetrating keratoplasty failure in 49 eyes (90.7%), chronic keratitis in 2 eyes (3.7%), ocular cicatricial pemphigoid in 1 eye (1.85%), Stevens Johnson syndrome in 1 eye (1.85%) and corneal vascularization in 1 eye (1.85%). Additionally, 40 eyes (74%) had preoperative glaucoma, and an Ahmed valve was implanted in 55% of them. Preoperative BCVA ranged from 20/200 to light perception. At an average follow-up of 20.15 months ± 12.7 (range, 1-56), postoperative vision improved to ⩾20/200 in 18 eyes (33.3%) and ⩾20/50 in 4 eyes (7.4%). The graft retention was 96%.
CONCLUSIONS:
The Boston Type 1 keratoprosthesis is a valid option for high-risk patients. The design improvements in the Boston keratoprosthesis, as well as the daily implementation of the therapeutic methods, have notably diminished occurrence of the most serious complications, such as corneal necrosis and endophthalmitis. As such, glaucoma and its subsequent complications now stand as the most prevalent prognostic factor in the long term.
AuthorsJose L Güell, Edilio Arcos, Oscar Gris, Diego Aristizabal, Miguel Pacheco, Claudia L Sanchez, Felicidad Manero
JournalSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society (Saudi J Ophthalmol) Vol. 25 Issue 3 Pg. 281-4 (Jul 2011) ISSN: 1319-4534 [Print] India
PMID23960937 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: